| Name | Title | Contact Details |
|---|---|---|
Laurent Chardonnet |
Vice President of Legal | Profile |
Heidy King-Jones |
General Counsel | Profile |
Heidy King-Jones |
General Counsel | Profile |
Heidy Abreu |
Vice President of Legal | Profile |
Gennao Bio is a privately held genetic medicines company developing first-in-class targeted nucleic acid therapeutics utilizing a proprietary gene monoclonal antibody (GMAB) platform technology.
Brampton Cosmetic Surgery is a Brampton, ON-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
ImmunityBio is a vertically-integrated, clinical-stage biotechnology company developing next-generation therapies and vaccines that bolster the natural immune system to defeat cancers and infectious diseases. The company`s range of immunotherapy and cell therapy platforms, alone and together, act to drive and sustain an immune response with the goal of creating durable and safe protection against disease. We are applying our science and platforms to treating cancers, including the development of potential cancer vaccines, as well as developing immunotherapies and cell therapies that we believe sharply reduce or eliminate the need for standard high-dose chemotherapy. These platforms and their associated product candidates are designed to be more effective, accessible, and easily administered than current standards of care in oncology and infectious diseases.
POINT Biopharma develops next-generation radioligand therapies for the treatment of cancer
Revolutionary Products for Soft Tissue Replacement and Regeneration